Incidence and outcomes of contralateral breast cancers

    Research output: Contribution to journalArticle

    52 Citations (Scopus)

    Abstract

    Background: The significance of a contralateral breast cancer is largely unknown, making prophylactic mastectomy controversial. Methods: Differences between stages of initial and contralateral cancers were determined by t test. Survival distributions were compared by log-rank analyses and compared with Surveillance Epidemiology and End Results data for unilateral cancers. Results: Metachronous contralateral cancers occurred at a rate of .13% per year and were of significantly lower stage. Metachronous cancers adversely impacted survival for patients with low-stage initial cancers, but the interval between cancers was less than 36 months. Synchronous tumors occurred in 2.3% of patients; survival was worse than for patients with metachronous cancers. Conclusions: Prophylactic mastectomy is unlikely to be beneficial because of the lower stages and low incidence of second cancers, even for patients with initial low-stage cancers.

    Original languageEnglish (US)
    Pages (from-to)645-650
    Number of pages6
    JournalAmerican Journal of Surgery
    Volume195
    Issue number5
    DOIs
    StatePublished - May 2008

    Fingerprint

    Breast Neoplasms
    Incidence
    Neoplasms
    Survival
    Second Primary Neoplasms
    Epidemiology

    Keywords

    • Breast cancer
    • Contralateral
    • Metachronous
    • Synchronous

    ASJC Scopus subject areas

    • Surgery

    Cite this

    Incidence and outcomes of contralateral breast cancers. / Quan, Glenda; Pommier, Su Ellen Johnson; Pommier, Rodney.

    In: American Journal of Surgery, Vol. 195, No. 5, 05.2008, p. 645-650.

    Research output: Contribution to journalArticle

    @article{4584993b6d6b4d5fb8b435bbdf4f8374,
    title = "Incidence and outcomes of contralateral breast cancers",
    abstract = "Background: The significance of a contralateral breast cancer is largely unknown, making prophylactic mastectomy controversial. Methods: Differences between stages of initial and contralateral cancers were determined by t test. Survival distributions were compared by log-rank analyses and compared with Surveillance Epidemiology and End Results data for unilateral cancers. Results: Metachronous contralateral cancers occurred at a rate of .13{\%} per year and were of significantly lower stage. Metachronous cancers adversely impacted survival for patients with low-stage initial cancers, but the interval between cancers was less than 36 months. Synchronous tumors occurred in 2.3{\%} of patients; survival was worse than for patients with metachronous cancers. Conclusions: Prophylactic mastectomy is unlikely to be beneficial because of the lower stages and low incidence of second cancers, even for patients with initial low-stage cancers.",
    keywords = "Breast cancer, Contralateral, Metachronous, Synchronous",
    author = "Glenda Quan and Pommier, {Su Ellen Johnson} and Rodney Pommier",
    year = "2008",
    month = "5",
    doi = "10.1016/j.amjsurg.2008.01.007",
    language = "English (US)",
    volume = "195",
    pages = "645--650",
    journal = "American Journal of Surgery",
    issn = "0002-9610",
    publisher = "Elsevier Inc.",
    number = "5",

    }

    TY - JOUR

    T1 - Incidence and outcomes of contralateral breast cancers

    AU - Quan, Glenda

    AU - Pommier, Su Ellen Johnson

    AU - Pommier, Rodney

    PY - 2008/5

    Y1 - 2008/5

    N2 - Background: The significance of a contralateral breast cancer is largely unknown, making prophylactic mastectomy controversial. Methods: Differences between stages of initial and contralateral cancers were determined by t test. Survival distributions were compared by log-rank analyses and compared with Surveillance Epidemiology and End Results data for unilateral cancers. Results: Metachronous contralateral cancers occurred at a rate of .13% per year and were of significantly lower stage. Metachronous cancers adversely impacted survival for patients with low-stage initial cancers, but the interval between cancers was less than 36 months. Synchronous tumors occurred in 2.3% of patients; survival was worse than for patients with metachronous cancers. Conclusions: Prophylactic mastectomy is unlikely to be beneficial because of the lower stages and low incidence of second cancers, even for patients with initial low-stage cancers.

    AB - Background: The significance of a contralateral breast cancer is largely unknown, making prophylactic mastectomy controversial. Methods: Differences between stages of initial and contralateral cancers were determined by t test. Survival distributions were compared by log-rank analyses and compared with Surveillance Epidemiology and End Results data for unilateral cancers. Results: Metachronous contralateral cancers occurred at a rate of .13% per year and were of significantly lower stage. Metachronous cancers adversely impacted survival for patients with low-stage initial cancers, but the interval between cancers was less than 36 months. Synchronous tumors occurred in 2.3% of patients; survival was worse than for patients with metachronous cancers. Conclusions: Prophylactic mastectomy is unlikely to be beneficial because of the lower stages and low incidence of second cancers, even for patients with initial low-stage cancers.

    KW - Breast cancer

    KW - Contralateral

    KW - Metachronous

    KW - Synchronous

    UR - http://www.scopus.com/inward/record.url?scp=42049102783&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=42049102783&partnerID=8YFLogxK

    U2 - 10.1016/j.amjsurg.2008.01.007

    DO - 10.1016/j.amjsurg.2008.01.007

    M3 - Article

    C2 - 18424281

    AN - SCOPUS:42049102783

    VL - 195

    SP - 645

    EP - 650

    JO - American Journal of Surgery

    JF - American Journal of Surgery

    SN - 0002-9610

    IS - 5

    ER -